Tag: Mydecine - Page 10 - Psychedelic Alpha

Read more about the article Mydecine Innovations Group Adds Former Pfizer, Novartis, Yale Drug Discovery Expert to Scientific Advisory Board

Mydecine Innovations Group Adds Former Pfizer, Novartis, Yale Drug Discovery Expert to Scientific Advisory Board

Post published:June 30, 2020
Post category:Press Release

Read more about the article Mydecine Innovations Group Bolsters Scientific Advisory Board Adding a Leading Neuroscientist and a Psychopharmacology Specialist

Mydecine Innovations Group Bolsters Scientific Advisory Board Adding a Leading Neuroscientist and a Psychopharmacology Specialist

Post published:June 23, 2020
Post category:Press Release

Read more about the article Mydecine Innovations Group Signs Definitive Agreement to Acquire Mindleap Health’s Advanced Digital Telehealth Platform

Mydecine Innovations Group Signs Definitive Agreement to Acquire Mindleap Health’s Advanced Digital Telehealth Platform

Post published:June 17, 2020
Post category:Press Release

Read more about the article Mydecine Innovations Group Inc. Signs Partnership Agreement With Applied Pharmaceutical Innovation

Mydecine Innovations Group Inc. Signs Partnership Agreement With Applied Pharmaceutical Innovation

Post published:June 12, 2020
Post category:Press Release

Read more about the article Mydecine Innovations Group to Acquire NeuroPharm Inc.

Mydecine Innovations Group to Acquire NeuroPharm Inc.

Post published:June 10, 2020
Post category:Press Release

Read more about the article NewLeaf Brands Announces Name and Stock Ticker Symbol Change to Mydecine Innovations Group Inc. (CSE: MYCO)

NewLeaf Brands Announces Name and Stock Ticker Symbol Change to Mydecine Innovations Group Inc. (CSE: MYCO)

Post published:June 1, 2020
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.